Skip to content

A Clinical trial on KADUKKAI POO CHOORANAM in the management of RATHA MOOLAM (BLEEDING HAEMORRHOIDS)

A prospective open labelled non-randomized phase II clinical trail of KADUKKAI POO CHOORANAM in the management of RATHA MOOLAM (BLEEDING HAEMORRHOIDS)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040253
Enrollment
40
Registered
2022-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K640- First degree hemorrhoids

Interventions

Intervention1: KADUKKAI POO CHOORANAM: 2-4gm twice a day (orally) with palm jaggery for 45 days. Control Intervention1: NIL: NIL

Sponsors

Government Siddha Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients presenting with the signs and symptoms such as rectal bleeding, mucus discharge from rectum,anal pain, anaemia and constipation. 2.Patients who are willing to take proctoscopical examination and provide blood samples for laboratory investigation.

Exclusion criteria

Exclusion criteria: 1.Patients with age below 20 years and above 55 years. 2.Patients presenting with the following conditions such as 2nd,3rd and 4th degree of haemorrhoids, pregnant and lactating women, external haemorrhoids.fissure in ano, fistula in ano, hypertension, rectal polyp, rectal cancer.

Design outcomes

Primary

MeasureTime frame
If during treatment and after treatment reduction of the following symptoms 1.Anal pain 2.Rectal bleeding 3.Anaemia 4.Constipation 5.Pus and mucus discharge from rectum. Timepoint: 45 days

Secondary

MeasureTime frame
1.To evaluate the pharmacological activities of trial drug. 2.Study about the prevalence of RATHA MOOLAM in relation between diet and lifestyle. 3.To determine antimicrobial activity of trail drug in different solvents. 4.To find out primary phytochemical analysis in trail drug. 5.To evaluate proctoscopical changes in internal haemorrhoids. 6.To evaluate safety profile for acute and subacute toxicity. 7.To perform bio chemical analysis.Timepoint: 45 days

Countries

India

Contacts

Public ContactDr AManoharanMDSPhD

Government Siddha Medical College and Hospital

drpsk_md@yahoo.in9944337757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026